Clinical Trials List
2015-09-01 - 2020-05-31
Phase III
Terminated7
ICD-10M46.90
Unspecified inflammatory spondylopathy, site unspecified
ICD-10M47
Spondylosis
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 劉明煇 Division of Rheumatology
- Chia-Tse Weng Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 陳相成 風濕免疫科
- Tsung-Yun Hou 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- WEN-NAN HUANG Division of Rheumatology
- HSIN-HUA CHEN Division of Rheumatology
- Yi-Hsing Chen Division of Rheumatology
- 洪維廷 Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yao-Fan Fang Division of Rheumatology
- 陳彥輔 Division of Rheumatology
- Chang-Fu Kuo Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
- TianMing Zhan Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
390 participants
